Physician profile
John A Freeman
NPI 1134104433
$3,812.13
in general payments reported to CMS, 2019-2025
10 companies · $307 in 2025
The $307 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,496 · 2020: $86.49 · 2021: $174 · 2022: $1,192 · 2023: $322 · 2024: $234 · 2025: $307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $863.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $863.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertiflex, INC. | $1,495.87 | 2019 | |
| Boston Scientific Corporation | $669.36 | 2022-2025 | Intracept |
| Nevro Corp. | $389.35 | 2022-2023 | Senza |
| Medtronic, INC. | $378.00 | 2023-2025 | Intellis Adaptivestim, Inceptiv |
| Abbott Laboratories | $355.38 | 2021-2022 | |
| Astellas Pharma US INC | $199.94 | 2022 | |
| Averitas Pharma INC. | $121.94 | 2023 | Qutenza |
| Viiv Healthcare Company | $92.96 | 2025 | |
| Spr Therapeutics, INC | $86.49 | 2020 | |
| Globus Medical, INC. | $22.84 | 2025 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Freeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.